skitahoe,
This lament goes right back to manufacturing preparedness. You can’t approve something you can’t supply to meet the demand. Think about what you said about Dr Ashkan using L in all cancer types. What kind of demand are we talking about? Huge right? Is it going to be a rich guys only treatment while you hope for manufacturing to catch up? That’s not very ethical is it? Want to know why NWBO has been so quiet for so long? How about regulators saying “You need a bigger boat”. Hence Flaskworks and help and a look from Dr Duffy on another front. I believe we have been waiting almost 7 years for manufacturing to catch up to expected demand and investors, including many on Wall Street, simply can’t wrap their heads around this PLATFORM technology. Everything has to be laid out ahead of time because of demand created by the good news which time turned into bad for investors unless investors chose to make time their friend by deliberate strategy.
I believe NWBO and regulators are almost ready to make joint announcements now. This quiet period seems to be a special case where Merck has sen the light and is being clued in as well. So, in my opinion, the quiet period involves NWBO, regulators and very likely Merck.
Dr Linda Liau and NWBO found a solution to a problem that created a problem that needed a solution. The solution to the problem created is now at hand. The curtain is about to rise finally. Best wishes.
AI
Market Data 
Markets 
